Skip to content
Reckitt Benckiser
Search
Join RB’s networks
Facebook
LinkedIn
Twitter
YouTube
Google Plus
Weibo
RB Early Life Blog
Share
Sitemap
HTML version
Text only version
RB worldwide
Global locations
Executive Committee
The Board
RB history
Vision and values
Contact us
Careers & students
Apply now
Why join us?
Jobs for professionals
Graduates & Interns
What it's like at RB
Brand Me
Just for fun
Innovators
Products
People
Awards
Our brands
Powerbrands on the shelf
Products around the home
Commercial break
Search RB Brands A-Z
Category performance
Healthcare Brands Employee Reporting
Suboxone, Subutex & Temgesic adverse events reporting
Our responsibility
betterbusiness
Our Home Our Planet
Trees for Change
Community
Healthier kids Happier homes
Policies & reports
Contact us
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Home
>
Investors & media
>
Corporate governance
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Corporate governance
The Company places a great deal of importance on high standards of corporate governance and has applied substantially all the detailed provisions laid down in the Combined Code on Corporate Governance.
The Company has appointed Graham Mackay as the Senior Independent Non-Executive Director.
The current Board comprises ten directors, eight of whom are non-executive. Peter Harf, Deputy Chairman, is not considered to be an independent Non-Executive Director because of the shareholding he represents and because he has served as a Director for more than nine years. Adrian Bellamy, Chairman of the Board, has also served more than nine years on the Board but was independent upon appointment as Chairman. The Governance Code states that the test of independence for the Chairman is not relevant if he was independent upon appointment. The Board structure adopted by the Company is similar to that of its key international competitor companies, most of whom are US-based.
The Company has established three committees of the Board: an Audit, a Remuneration and a Nomination Committee.
If you would like to view the terms of reference for these committees, please view the PDFs via the links on the right-hand side of the page.
Print this page
PDF Downloads
To view the terms of reference for these committees, please click on the headings below.
Audit Committee Terms of Reference November 2012.pdf
Terms of reference for the Reckitt Benckiser Group plc Audit Committee – updated November 2012
...read more
Remuneration Commitee Terms November 2012.pdf
Terms of reference for the Reckitt Benckiser Group plc Remuneration Committee – updated November 2012
...read more
Nomination Committee Terms November 2012.pdf
Terms of reference for the Reckitt Benckiser Group plc Nomination Committee – updated November 2012
...read more
Articles post May 10 AGM.pdf
Articles of association 2010
...read more
Non Audit Fees Policy.pdf
Non Audit Fees Policy updated November 2012
...read more